Get the Stockscreener App
5.53
3.95%
0.21
After Hours:
5.55
0.02
+0.36%
Recursion Pharmaceuticals Inc stock is traded at $5.53, with a volume of 56.58M.
It is up +3.95% in the last 24 hours and up +14.49% over the past month.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
See More
Previous Close:
$5.32
Open:
$5.52
24h Volume:
56.58M
Relative Volume:
2.02
Market Cap:
$2.36B
Revenue:
$64.60M
Net Income/Loss:
$-377.75M
P/E Ratio:
-3.5677
EPS:
-1.55
Net Cash Flow:
$-335.64M
1W Performance:
+0.00%
1M Performance:
+14.49%
6M Performance:
-3.99%
1Y Performance:
-16.47%
1-Day Range:
$5.25
$5.57
1-Week Range:
$5.11
$6.30
52-Week Range:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Name
Recursion Pharmaceuticals Inc
Sector
Industry
Phone
(385) 269-0203
Address
41S RIO GRANDE STREET, SALT LAKE CITY
Compare RXRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
5.53 | 2.32B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-22-23 | Initiated | Morgan Stanley | Equal-Weight |
| Mar-16-23 | Initiated | Needham | Buy |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-18-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-21-21 | Initiated | Berenberg | Buy |
| May-11-21 | Initiated | BofA Securities | Buy |
| May-11-21 | Initiated | Goldman | Neutral |
| May-11-21 | Initiated | JP Morgan | Neutral |
| May-11-21 | Initiated | KeyBanc Capital Markets | Overweight |
| May-11-21 | Initiated | SVB Leerink | Outperform |
View All
Recursion Pharmaceuticals Inc Stock (RXRX) Latest News
Is Recursion Pharmaceuticals on a Comeback Trail? - StocksToTrade
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Recursion Pharmaceuticals Inc. stock volume spike explainedRate Cut & Risk Adjusted Buy/Sell Alerts - newser.com
Using economic indicators to assess Recursion Pharmaceuticals Inc. potentialJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Advanced analytics toolkit walkthrough for Recursion Pharmaceuticals Inc.July 2025 News Drivers & Reliable Volume Spike Alerts - newser.com
Will Recursion Pharmaceuticals Inc. stock maintain growth story2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scanners2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
Recursion Pharmaceuticals Hits Day High with 16.44% Surge in Stock Price - Markets Mojo
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com
Promising Biotech Stocks To Follow NowOctober 11th - MarketBeat
Recursion Pharmaceuticals (RXRX): Assessing Valuation with AI Strategy in Focus Ahead of Key CEO Presentation - Yahoo Finance
How Investors Are Reacting To Recursion Pharmaceuticals (RXRX) AI Platform Spotlight Ahead of CEO's Dubai Talk - simplywall.st
Biotech Stocks To Follow TodayOctober 8th - MarketBeat
RXRX Stock: What’s Behind Recent Moves? - timothysykes.com
Recursion Pharmaceuticals (RXRX): Evaluating Valuation Ahead of CEO’s AI Conference Appearance and Growth Plans - simplywall.st
Recursion Stock: Can It Bounce Back? - StocksToTrade
Recursion Pharmaceuticals’ Stocks: A Deep Dive - timothysykes.com
Assessing Recursion Pharmaceuticals After Shares Surge 19% Amid AI-Driven Market Optimism - simplywall.st
Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX) - Seeking Alpha
Recursion Pharmaceuticals Stock (RXRX) Opinions on Recent Price Momentum - Quiver Quantitative
AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next - ts2.tech
Weiss Ratings Reiterates "Sell (D-)" Rating for Recursion Pharmaceuticals (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (RXRX) Climbs 16% Ahead of AI Conference - Yahoo Finance
Why Recursion Pharmaceuticals Stock Tanked on Tuesday - MSN
COST, AMD, RXRX, CIFR, SNOW: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
Best Pharmaceutical Stocks To Watch NowOctober 8th - MarketBeat
What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
Investors Buy Large Volume of Recursion Pharmaceuticals Call Options (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 5.8%Here's What Happened - MarketBeat
Recursion Pharmaceuticals Shares Surge Amid Strategic Growth - TipRanks
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025 - ts2.tech
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory - Yahoo Finance
Recursion Pharmaceuticals Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know - sharewise.com
RXRX Shares Plunge: Time to Bail Out? - StocksToTrade
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
Can Recursion Pharmaceuticals Inc. recover in the next quarterJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
How to recover losses in Recursion Pharmaceuticals Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Recursion Pharmaceuticals Inc. still worth holding after the dip2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Will Recursion Pharmaceuticals Inc. stock recover faster than market2025 Big Picture & Entry and Exit Point Strategies - newser.com
Should you wait for a breakout in Recursion Pharmaceuticals Inc.Trade Entry Summary & Real-Time Buy Zone Alerts - newser.com
Biotech Stocks To Watch NowOctober 4th - MarketBeat
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Why Recursion Pharmaceuticals (RXRX) Is Up 19.2% After Securing $12.5M Milestone in AI Drug Partnership - simplywall.st
Biotech Stocks To ResearchOctober 3rd - MarketBeat
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains? - Nasdaq
Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives - Yahoo Finance
Recursion Pharmaceuticals (RXRX): Assessing Valuation Following New Milestone Payment and Drug Development Progress - simplywall.st
Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionWeekly Profit Summary & Weekly Momentum Picks - newser.com
Published on: 2025-10-03 01:30:40 - newser.com
Recursion Pharmaceuticals Inc Stock (RXRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):